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Nanoparticles (NPs) are able to deliver a variety of substances into eukaryotic cells.
However, their usage is often hampered by a lack of specificity, leading to the
undesired uptake of NPs by virtually all cell types. In contrast to this, yeast is known
to be specifically taken up into immune cells after entering the body. Therefore, we
investigated the interaction of biodegradable surface‐modified poly(lactic‐co‐glycolic
acid) (PLGA) particles with yeast cells to overcome the unspecificity of the particulate
carriers. Cells of different Saccharomyces cerevisiae strains were characterized
regarding their interaction with PLGA‐NPs under isotonic and hypotonic conditions.
The particles were shown to efficiently interact with yeast cells leading to stable NP/
yeast‐complexes allowing to associate or even internalize compounds. Notably,
applying those complexes to a coculture model of HeLa cells and macrophages, the
macrophages were specifically targeted. This novel nano‐in‐micro carrier system
suggests itself as a promising tool for the delivery of biologically active agents into
phagocytic cells combining specificity and efficiency.
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1 | INTRODUCTION
Delivery of biologically active agents to specific cells or tissues
represents a promising therapeutic approach. However, effective
targeting of particular cell types still remains a significant challenge
with major obstacles. In the field of nonviral carrier systems,
nanoparticles (NPs) have been extensively studied as a vehicle for
immunotherapy (Amoozgar & Goldberg, 2015). Among the en-
ormous amount of different NP compositions described so far,
biocompatible polymers possess several advantages with regard to
stability, safety, or controlled‐release ability. Likewise, their high
variability in size and charge makes them a very interesting carrier
system for drugs, nucleic acids, or other biologically active agents
(Bala, Hariharan, & Kumar, 2004; Nafee, Taetz, Schneider, Schaefer,
& Lehr, 2007). The biodegradable and biocompatible poly(lactic‐co‐
glycolic acid) (PLGA), already being approved as generally recog-
nized as safe (GRAS) from the Food and Drug Administration
(FDA) and European Medicine Agency (EMA; Mir, Ahmed, &
Rehman, 2017), represents one of the most promising materials.
Additionally, PLGA‐NPs stand out from their high cargo capacity,
ease of production and modification, as well as the ability to escape
from early endosomes into the cytoplasm (Hamdy, Haddadi, Hung,
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& Lavasanifar, 2011). However, even though both uptake and
retention of nanoparticles in target cells can be enhanced by
modifying the surface with particular ligands or varying their
physicochemical properties, there is still a need for improvement to
eliminate off‐target accumulation and uptake by undesired cell
types (Brown, Pistiner, Adjei, & Sharma, 2019).
Macrophages are specialized cells involved in a variety of
immunological mechanisms comprising, amongst others, phagocytic
clearance, antigen processing and presentation, inflammatory or anti‐
inflammatory regulation, and tissue repair. This broad spectrum of
functions requires high phenotypic plasticity that is enabled by a
highly variable transcriptional repertoire responding to different
microenvironmental signals (Mosser & Edwards, 2008; Reinartz et al.,
2014). In fact, macrophages can undergo a spectrum of activation
states, wherein M1 and M2 represent two extremes (Biswas &
Mantovani, 2010; Verreck, de Boer, Langenberg, van der Zanden, &
Ottenhoff, 2006; Xue et al., 2014). Besides pathogen clearing and
activation of the adaptive immune response, M1 macrophages are
also involved in chronic inflammatory diseases and tumor repression,
whereas the M2 subtype behaves immunosuppressive and promotes
tumor growth (Murray & Wynn, 2011). Accordingly, the re‐education
of macrophages represents a very promising strategy in different
therapeutic approaches for cancer or arthritis, and several sub-
stances with reprogramming effects have already been described
(Jain, Tran, & Amiji, 2015; Rubio et al., 2019; Wang et al., 2017).
Amongst others, imiquimod, interferon‐γ (IFN‐γ), and interleukin‐12
(IL‐12) have been demonstrated to exert an antitumor function, but
would lead to severe off‐target effects after systemic administration
(Dewan et al., 2012; Dunn, Koebel, & Schreiber, 2006; Wang et al.,
2017). Thus, to avoid such negative side effects, there is a strong
need for an effective and safe cell‐specific delivery system.
Yeast cells have been repeatedly proven to be a remarkably
efficient delivery vehicle for targeting a whole bunch of cargos to
phagocytic cells in general and macrophages in particular (Bazan,
Geginat, Breinig, Schmitt, & Breinig, 2011; Seif, Hoppstädter, Breinig, &
Kiemer, 2017; Seif, Philippi, Breinig, Kiemer, & Hoppstadter, 2016;
Stubbs et al., 2001;Walch, Breinig, Schmitt, & Breinig, 2012). Among the
different yeast genera, the well‐characterized baker’s yeast Sacchar-
omyces cerevisiae possesses the GRAS status facilitating a possible
application as a carrier system, thereby providing the advantages of a
single cell organism including easy handling and genetic modification. In
addition, S. cerevisiae harbors the opportunity of oral delivery as it is able
to protect a cargo from degradation by acidic pH or proteases during
gastrointestinal passage and is efficiently taken up by specialized M cells
in the gut (Beier & Gebert, 1998; Kenngott et al., 2016). Furthermore,
glucan particles, derived from the cell wall of S. cerevisiae, have already
been successfully examined for oral as well as systemic delivery of NPs
to macrophages (Soto, Caras, Kut, Castle, & Ostroff, 2012; Soto &
Ostroff, 2008). In addition, positively charged nanoparticles could be
effectively loaded into yeast capsules by electrostatic forces‐mediated
spontaneous deposition (Ren et al., 2018; Zhou et al., 2017).
In this study, we aimed to establish a completely GRAS nano‐in‐
micro delivery system for macrophages by combining the
advantages of yeast cells and PLGA‐NPs. We show that PLGA‐
NPs strongly interact with yeast cells and the generated yeast/NP
complexes are targeted specifically to macrophages with high
efficiency. This system raises the possibility to deliver a variety of
biologically functional agents to macrophages for being used in
therapeutic approaches.
2 | MATERIALS AND METHODS
2.1 | Yeast strains and cell culture
S. cerevisiae strains S86c [MATα ura3‐2 leu2 his3 pra1 prb2 prc1 cps1]
and BY4742 [MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0] were grown in
YPD (1% yeast extract, 2% peptone, 2% glucose) at 30°C and
220 rpm. For fluorescence labeling, 107 yeast cells were harvested by
centrifugation (14,000×g, 5 min), washed with phosphate‐buffered
saline (PBS; Biochrom, Berlin, Germany), and stained with 2.5 μM
carboxyfluorescein diacetate succinimidyl ester (CFSE; Life Technol-
ogies, Carlsbad, CA) for 30min at 37°C. CFSE‐stained yeast cells
were washed twice with PBS to remove the residual dye and
opsonized by incubation with 25% human serum for 30min at 37°C.
The human cervix tumor cell line HeLa was cultured in Roswell
Park Memorial Institute 1640 (RPMI‐1640) supplemented with 10%
fetal bovine serum (FBS) (Sigma‐Aldrich, St. Louis, MO), 100 U/ml
penicillin, 100mg/ml streptomycin, and 2mM glutamine. Cells were
cultivated in a humidified atmosphere with 5% CO2 at 37°C and
passaged twice a week. The human monocyte cell line THP‐1 (ATCC®
TIB‐202™) was cultured in RPMI‐1640 medium (Sigma‐Aldrich)
supplemented with 10% FBS; Biochrom). Cells were grown in a
humidified 5% CO2 atmosphere at 37°C. Monocytes were differ-
entiated into M1 or M2 macrophages as previously described by
adding 30 ng/ml phorbol 12‐myristate‐13‐acetate (PMA; Sigma‐
Aldrich; Hoppstädter et al., 2015; Kiemer et al., 2009). After 48 hr,
cells were stimulated for another 40 hr with 1 μg/ml LPS (Sigma‐
Aldrich) and 20 ng/ml recombinant human IFN‐γ or 200 ng/ml
recombinant human IL‐10 (both from Miltenyi Biotec, Bergisch
Gladbach, Germany), respectively.
2.2 | Isolation and culture of primary human
monocyte‐derived macrophages
The isolation of primary cells from human material was authorized by
the local ethics committee (State Medical Board of Registration,
Saarland, Germany; permission no. 173/18). Human monocytes were
isolated from buffy coats obtained from anonymous healthy blood
donors (Blood Donation Center, Saarbrücken, Germany). Peripheral
blood mononuclear cells (PBMC) were separated by density gradient
centrifugation using Lymphocyte Separation Medium 1077 (Promo-
Cell, Heidelberg, Germany) in Leucosep tubes (Greiner Bio‐One,
Kremsmünster, Austria). PBMC were washed in PBS and monocytes
were separated by positive selection using magnetic anti‐CD14
microbeads (Miltenyi Biotec). For macrophage differentiation, mono-
cytes were cultured at a density of 1.5 × 107 cells per 175 cm2 flask in
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RPMI‐1640 medium supplemented as above and 20 ng/ml human
recombinant macrophage colony‐stimulating factor (M‐CSF; Miltenyi
Biotec) for 5 days, as described previously (Seif, Philippi, Breinig,
Kiemer, & Hoppstädter, 2016). Macrophages were maintained at
37°C in a humidified atmosphere of 5% CO2, and the medium was
changed every second day.
2.3 | Nanoparticles
The nanoparticles were prepared using the solvent‐diffusion eva-
poration technique as similar to Nafee et al. (2007) in a one‐pot
approach. In brief, 50mg of rhodamine‐labeled PLGA (prepared as
described by Lababidi et al., 2019) were dissolved in 4.5 ml ethyl
acetate (Thermo Fisher Scientific, Schwerte, Germany). In parallel
7.5 ml of an aqueous 2% polyvinyl alcohol (PVA; Mowiol 4‐88,
Kuraray Europe, Hattersheim, Germany) solution containing 22mg of
chitosan (Protasan UP CL 113, NovaMatrix, Dupont, Sandvika,
Norway) was prepared. Afterward, the two solutions were mixed
with each other using an ultrasound device (MS73 head, Sonoplus
HD 3100, Bandelin electronic GmbH & Co. KG, Berlin, Germany) at
30% amplitude for 30 s. Then to obtain the hypotonic particle
solution, 45ml of MiliQ water (Merck Millipore, Darmstadt,
Germany) was added and the mixture was left overnight under
stirring to remove the organic solvent.
To obtain the particles dispersed at nearly isotonic conditions,
67mg NaCl (Carl Roth, Karlsruhe, Germany) was added to the 2%
PVA solution (with or without chitosan) before combining with the
PLGA containing phase. After particle formation, the volume was
increased by adding 45ml of 0.9% NaCl. Colloidal properties of the
particles were determined with a Zetasizer Nano (Malvern, Malvern,
UK) and are displayed in Table 1 indicating the sizes and the small
size distributions.
2.4 | Yeast–nanoparticle interaction
For interaction studies, 107 yeast cells were harvested by centrifuga-
tion (14,000 ×g, 5 min), resuspended in 100 µl of the corresponding
nanoparticle solution (0.03–1mg/ml in isotonic [154mM] as well as
hypotonic [5 mM] NaCl solution) and incubated for 1 hr at 20°C with
gentle shaking. Afterward, the yeast/NP suspension was diluted with
sterile H2O resp. PBS, layered over 13% sucrose, and centrifuged at
600 × g in a swing bucket rotor for 10min without brake to separate
unbound particles from yeast cells, if needed. For analysis of
membrane integrity, yeast cells were stained with propidium iodide
(PI) for 5min (final concentration 5 µg/ml). After washing with PBS,
30,000 cells were analyzed via flow cytometry on a BD LSRFortessa™
using the FACSDiva™ software (BD Biosciences, Franklin Lakes, NJ).
To further characterize the yeast/NP interaction, yeast cells were
stained with Concanavalin A CF™488 A (50 µg/ml, Biotium, Free-
mont, CA) for 30min at RT. After washing with PBS, stained yeast
cells were incubated with NPs as described above. The resulting
solution was mixed at a ratio of 3:2 with FluorSave™ reagent
(Calbiochem®), spotted on a slide, and topped with a coverglass.
After approximately 1 hr, the sample was examined using a Zeiss
Axio Observer with an LSM 710 Scanning Module and ZEN 2 (blue
edition) software (Zeiss, Jena, Germany).
2.4.1 | Electron microscopy
For transmission electron microscopy (TEM) a droplet of the
respective solution was placed onto a holey carbon TEM grid (type
S147‐4; Plano, Wetzlar, Germany) and dried at ambient conditions.
TEM analysis was performed using a Jeol (Akishima, Tokio, Japan)
JEM‐2100 LaB6 transmission electron microscope operating at
200 kV accelerating voltage. A Gatan (Pleasanton, CA) Orius
SC1000 CCD camera was used to get TEM bright‐field images with
1024 × 1024 pixels (binning 2, acquisition time 0.5 s).
For scanning electron microscopic (SEM) imaging a droplet of the
sample solution was rinsed over a holey carbon grid (type S 147‐
4; Plano, Wetzlar, Germany), dried at air and fixed to the SEM sample
holder using double‐sided carbon tape. A thin layer of gold‐palladium
(ratio 60:40) was deposited onto the samples using magnetron
sputter deposition (Jeol JFC‐1300, 20mA, 30 s). Secondary electron
imaging was performed using an FEI Quanta 400 FEG under high
vacuum conditions at 20 kV accelerating voltage.
2.5 | Uptake of yeast/NP complexes by
macrophages
2.5 × 105 cells/ml THP‐1 monocytes were seeded into 35mm dishes
(ibidi, Martinsried, Germany), polarized into M1 and M2 MΦ as
described above and incubated with NP‐complexed yeast cells at a
multiplicity of infection (MOI) of 5 or 50 µg/ml NPs for 16 hr at 37°C
and 5% CO2. After two washing steps with PBS, cells were stained
with CellMask™ Green (Life Technologies) for 5 min at 37°C, fixed
with 4% formaldehyde and counter‐stained with 4′,6‐diamidino‐2‐
phenylindole (DAPI). Finally, macrophages were covered with phenol
red‐free RPMI‐1640 and analyzed with a Zeiss Axio Observer and
LSM 710 Scanning Module (Zeiss, Jena, Germany). Z‐stack images
were collected in 1 µm sections and presented as an orthogonal view
using ZEN 2 (blue edition) software (Zeiss).
For additional quantitative analyses, THP‐1 monocytes were
seeded at a density of 2.5 × 105 cells/ml in 24‐well plates,
TABLE 1 Physicochemical characteristics of chitosan‐coated
nanoparticles in 5 and 154mM NaCl solution (n = 3, mean ± SD)
NaCl
5mM 154mM
Size (nm) 237.5 ± 3.2 202.3 ± 2.7
PDI 0.09 ± 0.018 0.046 ± 0.006
ζ‐Potential (mV) 11.6 ± 1.4 3.25 ± 0.3
Conductivity (mS/cm) 0.516 ± 0.014 19.4 ± 1.7
pH 3.97 ± 0.3 3.9 ± 0.2
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differentiated into macrophages and treated with yeast/NP com-
plexes as described above. Subsequently, macrophages were washed
two times with PBS and detached using a cell scraper. After
centrifugation (300 ×g, 10 min) cells were resuspended in 1%
formaldehyde and 10,000 macrophages were examined on a BD
LSRFortessa™ using BD FACSDiva™ software (BD Biosciences).
2.6 | Coculture and uptake studies
Primary monocyte‐derived macrophages (MDM) were isolated and
differentiated as described above. On Day 5, macrophages were
harvested using accutase solution (Sigma) and stained with cell
tracker deep red dye (Thermo Fisher Scientific) in a working
concentration of 500 nM dissolved in RPMI‐1640 for 30min at
culturing conditions. HeLa cells were harvested by trypsin detach-
ment and stained with 5 µM cell tracker violet BMQC (Thermo Fisher
Scientific) for 30min. Cells were washed twice with PBS and
suspended in the culture medium. HeLa and macrophages were
cultured in a 1:1 ratio (2.5 × 105 cells, each, seeded in six‐well plates)
for 24 hr. For uptake studies, free rhodamine‐labeled nanoparticles
(NPs) or NPs complexed to CFSE‐stained yeast (as described above)
were added to the coculture at 37°C in 5% CO2 for 0.5 or 4 hr. Yeast
cells were added at a MOI of 5, and plain NPs in the corresponding
amount that was loaded to yeast (which equals 38 µg). Plates were
briefly centrifuged to ensure that yeast and the cell coculture were in
close contact. After incubation, supernatants were collected, and
cells were harvested using PBS containing 5mM ethylenediaminete-
traacetic acid. Supernatants together with harvested cells were
centrifuged, resuspended in 1% formaldehyde in PBS, and examined
via flow cytometry as described above. A small fraction of analyzed
cells (4.2% ± 2.1 SD) were cell tracker deep red and violet double
positive. We suggest that this occurred from the engulfment of HeLa
cell debris by macrophages. These cells were excluded from further
analysis to allow a cell type‐specific examination of NP uptake.
2.7 | Determination of cell viability
The 3‐(4,5‐dimethyl‐thiazol‐2‐)‐2,5‐diphenyl tetrazolium bromide
(MTT) colorimetric assay was used to analyze the toxic effect of
NPs on yeast cells. After incubation with the indicated NP solution,
yeast cells were washed with YPD and supplemented with 100 µg/ml
MTT for 2 hr at 30°C. Cells were then solubilized using dimethyl
sulfoxide and absorption was measured at 550 nm in a microplate
reader SpectraMax® Paradigm® Multi‐Mode Microplate Platform
using Multi‐Mode Analysis Software (Molecular devices). To analyze
the effect of yeast/NP complexes on the viability of macrophages,
THP‐1 monocytes were differentiated into macrophages by adding
30 ng/ml PMA for 48 hr. Macrophages were cocultured overnight
with yeast cells or yeast/NP complexes (MOI 5) and harvested using
PBS. Cells were then stained with 2 µg/ml PI on PBS for 10min at
4°C. After washing with PBS, 10,000 cells were analyzed via flow
cytometry on a BD LSRFortessa™ using the FACSDiva™ software (BD
Biosciences, Franklin Lakes, NJ).
3 | RESULTS
3.1 | Interaction of yeast cells with chitosan‐coated
PLGA particles
The ability of yeast cells to transport proteins, nucleic acids, or other
biologically active agents into mammalian phagocytic cells has been
shown repeatedly (Bazan, Breinig, Schmitt, & Breinig, 2014; Bazan
et al., 2011; Seif, Hoppstädter, Breinig, & Kiemer, 2017; Walch,
Breinig, Geginat, Schmitt, & Breinig, 2011; Walch‐Rückheim, Kiefer,
Geginat, Schmitt, & Breinig, 2016). To extend the described variety of
applications, we investigated the capability of S. cerevisiae to
associate with chitosan‐coated PLGA nanoparticles to target the
NPs specifically to phagocytes. Therefore, cells of two S. cerevisiae
strains (BY4742 and S86c) were incubated with NPs at different
concentrations ranging from 0.03 to 1mg/ml. In preliminary
experiments, the zeta potential of both strains was determined:
based on their particular cell wall composition, the strains were
found to differ in surface charge (−16mV for BY4742 and −11mV
for S86c) and, thus, might interact differently with the NPs.
Additionally, as the NaCl concentration was found to possess a
major impact on the interaction between positively charged
nanoparticles and yeast cells (Nomura et al., 2013), we studied and
characterized the yeast‐NP association in both isotonic (154mM) as
well as hypotonic NaCl solution (5mM).
After incubation with the respective rhodamine‐tagged NP
solution under hypotonic conditions, flow cytometric analyses
revealed very high amounts of yeast cells positive for particle‐
associated fluorescence as expected due to a lower shielding of the
charge. The particle‐associated fluorescence was ranging from 86%
to almost 100% overall NP concentrations apart from the lowest
(Figure 1a). In contrast, isotonic conditions not only yielded clearly
less NP‐positive yeast cells with a maximum of 68% at the highest NP
concentration but also a slower increase in the amount of rhodamine‐
positive yeast cells towards higher concentrations.
Regarding the mean fluorescence intensities reflecting the
number of interacting NPs, the influence of the NaCl concentration
becomes even more distinct (Figure 1b) with a maximum intensity of
1,000 for isotonic and up to 13,000 (BY4742) and 10,000 (S86c),
respectively, for hypotonic salt concentrations. Remarkably, under
low‐salt conditions, fluorescence intensity peaks reliably at a
concentration of 0.25mg/ml. These data indicate that both S.
cerevisiae strains are able to interact effectively with chitosan‐
coated NP, especially under hypotonic conditions, with a slight bias
regarding the interaction strength towards BY4742. Additionally,
scanning electron microscopy (SEM) of chitosan‐coated PLGA NP
and the respective yeast/NP complexes proved the interaction of
yeast cells and NPs (Figure 2).
Based on these results, we investigated by confocal fluorescence
microscopy if NPs simply bind to yeast cells or even become
internalized (CLSM; Figure 3). Therefore, cells of both yeast strains
were exposed to rhodamine‐tagged NPs under hypotonic conditions
using concentrations of 0.25 and 1mg/ml. Additionally, the yeast cell
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wall was stained with ConA‐488 allowing a better visualization of
particle adhesion and/or internalization in relation to the cell surface.
Whereas the control cells without NPs showed only green
fluorescent cell walls, addition of NPs at high concentration led to
a distribution of red fluorescence all over the yeast cells in both
strains, again with a higher signal intensity for BY4742 (cf. Figures 3a
and 3b). Fluorescence intensity profiles of representative cells
confirm these observations indicating both, particle binding to the
cell wall as well as internalization by the yeast cells under these
conditions. On the other hand, lower NP concentration led to a
pronounced particle accumulation at the cell wall in BY4742 and,
although to a lesser extent, also in S86c as likewise approved by the
colocalization of green and red fluorescence within the respective
cells. As already depicted in Figure 1b the rhodamine fluorescence
intensities of yeast cells incubated with NPs under isotonic
conditions are very low compared with hypotonic conditions and,
thus, a possible interaction between yeast cells and NPs could not be
visualized via CLSM in isotonic salt concentrations. Taken together,
(a)
(b)
F IGURE 1 Interaction of two different Saccharomyces cerevisiae strains with rhodamine‐tagged chitosan‐coated poly(lactic‐co‐glycolic acid)
(PLGA) particles. Yeast cells were incubated in 100 µl of the respective nanoparticle solution for 1 hr at 20°C. Rhodamine fluorescence was
analyzed by flow cytometry. Data in the top row (a) represent the percentage of rhodamine‐positive yeast cells of the strains BY4742 (left) and
S86c (right). Corresponding mean fluorescence intensities are displayed in the bottom row (b)
F IGURE 2 Distribution of NPs on the
yeast cell surface. Yeast cells of the strain
BY4742 were incubated with 1mg/ml NPs
(5 mM NaCl) for 1 hr and examined via
SEM. Representative images of both, the
original nanoparticle solution (left), and
yeast/NP complexes (right) are shown. NP,
nanoparticle; SEM, scanning electron
microscopy
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interactions of both analyzed S. cerevisiae strains with chitosan‐
coated NPs could be demonstrated. Due to the fact, that our data
suggest a somewhat higher NP‐binding efficiency in BY4742, we
focused on this strain in all further experiments.
3.2 | Effect of chitosan‐coated PLGA particles on
yeast cells
The observed strong interaction of yeast cells with NPs rose the
question if binding of the particles to or internalization by the yeast
(a)
(b)
F IGURE 3 CLSM images of yeast cells after incubation with rhodamine‐tagged PLGA particles. Displayed are yeast cells of the strains
BY4742 (a) and S86c (b) incubated with 1 and 0.25mg/ml NP solution (5 mM NaCl) or water for the control. Yeast cell walls were stained with
ConA‐488. In the right column, one representative fluorescence intensity profile is shown for each sample. CLSM, confocal laser scanning
microscopy; NP, nanoparticle; PLGA, poly(lactic‐co‐glycolic acid) [Color figure can be viewed at wileyonlinelibrary.com]
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cells affects membrane integrity and, eventually, cell viability. As
membrane integrity can be verified by PI staining, BY4742 cells were
incubated for 1 hr with different amounts of untagged NPs (i.e.
without rhodamine) and PI‐positive cells were quantified by FACS
analyses. Under hypotonic conditions, about 90% of the yeast cells
were PI‐positive over a wide range of NP concentrations,
clearly indicating the formation of pores in the yeast cell membrane
(Figure 4a). In sharp contrast, under isotonic conditions, virtually no PI‐
positive cells could be detected. However, as the impairment of
membrane integrity is not necessarily associated with a decreased
viability, we performed MTT assays to test the actual viability of
yeast cells (Figure 4b). In direct comparison with the isotonic setting,
yeast viability evidently correlated with NP concentrations with a
significant reduction above 0.25mg/ml NPs under hypotonic
conditions, reducing survival to 30% at the highest concentration. At
lower NP concentrations, no significant difference between low and
high salt incubation could be detected. Comparable results were
obtained in corresponding plate assays (not shown). In sum, these
findings imply that chitosan‐coated NPs weaken membrane integrity
of yeast cells under hypotonic but not under isotonic conditions.
However, this interaction impairs the viability of yeast cells merely at
high NP concentration.
3.3 | Uptake of yeast/NP complexes by
macrophages
Recognition and subsequent uptake of the respective carrier by
phagocytic cells is an important prerequisite for efficient delivery into
these cells. Thus, we performed preliminary experiments to ensure
effective phagocytosis of BY4742 cells by M1‐ and M2‐polarized
macrophages derived from human THP‐1 monocytes. CFSE‐stained
yeast cells were opsonized with human serum or left untreated and
(a)
(b)
F IGURE 4 Influence of PLGA‐NPs on membrane integrity and
viability of Saccharomyces cerevisiae BY4742. Yeast cells were
incubated with different concentrations of NPs dispersed in either
5mM or 154mM NaCl solution. (a) Cells were stained with
propidium iodide and analyzed via flow cytometry. Data are
presented as percentage of PI‐positive cells ± SD of three
independent samples. (b) Viability of yeast cells based on an MTT
assay. Data represent the absorption means ± SD of four
independent samples. MTT, 3‐(4,5‐dimethyl‐thiazol‐2‐)‐2,5‐diphenyl
tetrazolium bromide; NP, nanoparticle; PI, propidium iodide; PLGA,
poly(lactic‐co‐glycolic acid). p values were generated by Student’s t
test (**p < .005, ***p < .001)
(a)
(b)
F IGURE 5 Uptake of Saccharomyces cerevisiae by M1‐ and
M2‐polarized THP‐1 macrophages. MΦ were incubated with
CFSE‐stained yeast cells at MOI 5 for 4 hr. The mean fluorescence
intensity of CFSE‐positive macrophages was determined by flow
cytometry. (a) Comparison of untreated and opsonized yeast cells. (b)
Uptake of NP‐loaded yeast in different NaCl concentrations
compared with unloaded control cells. Experiments were performed
in doublets. CFSE, carboxyfluorescein diacetate succinimidyl ester;
MOI, multiplicity of infection; NP, nanoparticle. p Values were
generated by Student’s t test (*p < .05)
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incubated with M1 or M2 macrophages at MOI 5; subsequently,
macrophages that had taken up yeast cells were quantified via flow
cytometry based on their CFSE‐positive signal (Figure 5a). Although not
fully statistically significant (p = .07) for M1, in either case, opsonized
yeast cells showed a higher uptake rate than untreated yeast cells. This
observation is in accordance with our previous data on the uptake of
non‐opsonized yeast cells by primary human macrophages (Seif et al.,
2016). Accordingly, opsonized yeast was used for all further experi-
ments. Since the recognition of yeast cells by macrophages is based on
the interaction of specific receptors on the macrophages with their
respective ligand within the yeast cell wall, we next investigated if the
coating of yeast cells with NPs has any influence on this interaction. This
is clearly not the case as yeast/NP complexes produced either under
isotonic or hypotonic conditions did not show a reduced uptake,
excluding any negative side effect of the NPs on the recognition or
uptake of the yeast cells by the macrophages (Figure 5b). Interestingly,
the yeast/NP complexes actually showed a slight tendency towards
better uptake, especially in M2 macrophages. To rule out any negative
effect of yeast/NP complexes on macrophages, a viability test was
performed using PI staining. Therefore, BY4742 yeast cells were
complexed with unlabeled NPs and cocultured with macrophages
overnight at an MOI of 5. Compared to untreated control cells, there
was no impairment of cell viability detectable (Figure S1).
Afterward, we tested the targeting of yeast/NP complexes to
macrophages in comparison to a pure NP solution (50 µg/ml). Therefore,
BY4742 yeast cells were preincubated with rhodamine‐labeled NP
solutions (1mg/ml) under low/high salt conditions and separated from
unbound particles via density gradient centrifugation indicating that
approx. 62% of the NPs remained in the aqueous solution. The
separation of free NPs was visualized via TEM (Figure S2). The received
yeast/NP complexes were then cocultivated with prepolarized M1 and
M2 macrophages at MOI 5 for 16 hr; untreated macrophages served as
(a) (b)
(c)
F IGURE 6 Delivery of rhodamine‐tagged NPs to macrophages via yeast cells. M1 and M2 MΦ were incubated for 16 hr with NPs only or
NP‐complexed yeast cells and were stained with DAPI (nucleus, blue) and CellMask (cytosol, green). Yeast cells were preincubated with NPs
dispersed in either 5 or 154mM NaCl solution. (a) Quantitative analysis via flow cytometry; data represent the percentage of DAPI/rhodamine‐
positive MΦ ± SD of three independent samples. (b) Fluorescence intensity of M1 and M2 MΦ normalized to the applied amount of NPs. (c)
Orthogonal view of CLSM images showing M1 (top row) and M2 MΦ (bottom row). The central image shows the horizontal (x–y) section; top
and side panels represent the x–z and y–z planes, respectively. CLSM, confocal laser scanning microscopy; DAPI, 4′,6‐diamidino‐2‐phenylindole;
NP, nanoparticle [Color figure can be viewed at wileyonlinelibrary.com]
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a negative control. Subsequently, particle internalization with or without
yeast cells was assessed via flow cytometry based on a DAPI
(macrophages)/rhodamine (NPs) double fluorescence. In this setting,
yeast/NP complexes produced under hypotonic conditions were taken
up with the highest efficacy in both M1 and M2 macrophages compared
with isotonic conditions, and, remarkably, also to the much higher
concentrated pure NPs (Figure 6a). Among the subtypes, there was a
bias to M1 in comparison to M2 macrophages for plain NPs as well
as yeast/NP complexes under hypotonic conditions, respectively. The
lowest particle‐associated fluorescence was observed for yeast/NP
complexes produced in isotonic solution with values clearly below 10%
in either case, with a very slight bias to M2 macrophages.
However, although these data prove the successful targeting of
the yeast/NP complexes to macrophages, they do not reflect the real
amount of delivered particles. This is mainly based on the fact that
yeast/NP complexes contain only a fraction of the particle amount
originally used for complexation (~38% bound NPs as determined by
gradient centrifugation). To take this into account, we normalized the
respective mean fluorescence intensities to the applied amount of
particles actually bound to the yeast cells (Figure 6b). The resulting
values make the gain in delivery efficacy by using S. cerevisiae cells as
NP carrier even more apparent as the fluorescence intensity using
hypotonic “loaded” yeast/NP complexes is up to six times higher in
M1 and three times higher in M2 macrophages in comparison to the
same amount of “free” NPs. Now, even the isotonic‐“loaded” yeast/
NP complexes are at least as effective as the “free” NPs, again with a
slight bias towards M2‐polarized macrophages. Visualization of
particle uptake via confocal laser scanning microscopy further
confirmed the FACS data, clearly underlining an effective delivery
of the yeast/NP complexes into both M1 and M2 macrophages
(Figure 6c). NP aggregation within the medium can be observed in
the samples treated with NPs alone and has already been reported
by Nafee, Schneider, Schaefer, and Lehr (2009). Interestingly, and of
importance for delivery approaches, this aggregation is diminished by
complexation of NPs to yeast cells and the formation of unwanted
NP conglomerates is completely avoided after treatment with yeast/
NP complexes (Figure 6c).
3.3.1 | Targeted delivery of yeast/NP complexes to
macrophages within coculture
In the next step, we used a coculture model consisting of primary
human macrophages and HeLa cells to test whether yeast/NP
complexes are able to specifically target phagocytic cells and, thus,
diminish the unspecific and unwanted uptake of NPs by other cell
types. In this system, cocultured cells were incubated with equal
amounts of NPs either as free NPs or NP/yeast complexes and the
percentage of rhodamine‐positive HeLa cells and macrophages was
determined by flow cytometry (Figure 7). The representative
dotplots shown in Figure 7a demonstrate the expected uptake of
free NPs by HeLa cells and macrophages as indicated by the shift of
both populations after 4 hr towards rhodamine positivity. In contrast,
using NP/yeast complexes, a strong bias of the NP uptake towards
macrophages could be observed. Moreover, quantification of the
rhodamine‐positive mammalian cells revealed that complexation with
yeast not only positively affected cell targeting but also increased the
NP uptake efficacy in general from 34% to 91%. Likewise, this
approach yielded an acceleration of the NP uptake by the yeast
vehicles: after 0.5 hr, already 78% of the macrophages were
rhodamine positive compared with only 6% after incubation with
free NPs (Figure 7b). Interestingly, the salt concentration seems to
have an influence on the NP uptake by macrophages. While there is
no observable difference with free NPs, the amount of NP‐positive
macrophages incubated for 0.5 hr with NP/yeast complexes prepared
in hypotonic solution is significantly higher (76%) compared with the
corresponding sample prepared in an isotonic milieu (40%, Figure 7c).
However, this effect is compensated after 4 hr incubation. To rule out
that the preparation of the yeast/NP complexes under different
osmotic conditions affects the uptake of the complexes, the
phagocytosis rate of macrophages was measured by flow cytometry
using CFSE‐stained yeast cells. This analysis resulted in more than
96% CFSE‐positive macrophages already after 0.5 hr incubation time
for both NaCl concentrations, thus excluding a possible negative
effect of the complexation conditions (Figure S3).
4 | DISCUSSION
Macrophages possess a broad spectrum of phenotypes resulting in a
variety of protective as well as pathogenic functions (Mosser &
Edwards, 2008; Murray & Wynn, 2011). In particular, their
involvement in chronic inflammatory diseases and tumor promotion
makes this cell type a promising target for therapeutic approaches. In
this respect, NPs have recently been successfully used as a carrier to
MΦ in several studies, delivering for example drugs or cytokines
(Amarnath Praphakar, Munusamy, Sadasivuni, & Rajan, 2016;
Mantovani, Sozzani, Locati, Allavena, & Sica, 2002; Wang et al.,
2017). Nonetheless, the usage of NPs strongly suffers from the lack
of cell‐specific targeting, possibly leading to severe off‐target effects
(Brown et al., 2019; Merkel et al., 2011). Yeast cells have already
F IGURE 7 Uptake of rhodamine‐labeled nanoparticles (NPs) by cocultured HeLa cells and primary human macrophages (MΦ). Cocultures
were incubated with either plain NPs or opsonized NP‐carrying Saccharomyces cerevisiae for 0.5 or 4 hr. The percentage of rhodamine‐positive
HeLa and macrophages was determined by flow cytometry; samples taken at 0 hr served as a negative control. (a) Representative dot plots for
treatment with hypotonic NPs or NP/yeast complexes are shown. (b) Quantitative analysis comparing the uptake of plain NPs (left) and NP/
yeast complexes (right) in HeLa and MΦ. (c) Quantitative analysis comparing uptake of isotonic and hypotonic NPs in macrophages, either as
plain NPs (left) or as NP/yeast complexes (right). The mean values ± SEM of two independent experiments performed in cells from different
donors and measured in duplicates each are shown. p Values were calculated by one‐way analysis of variance (***p < .001)
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been proven to represent an effective delivery vehicle for the specific
targeting of phagocytes. Consequently, a nano‐in‐micro carrier
consisting of NP‐loaded S. cerevisiae cells would be a promising
approach to accomplish an efficient and precise targeting to MΦ
(Bazan et al., 2011; Kenngott et al., 2016; Walch et al., 2011, 2012;
Walch‐Rückheim et al., 2016).
Therefore, in this study, the interaction between yeast cells and
chitosan‐coated PLGA particles was characterized. Previous studies
have shown that the attractive electrostatic force between cells and
NPs is not only dependent on the particle composition itself, but also on
the ionic strength in the surrounding medium. Miyazaki et al. (2014)
found that the NaCl content in the solution has a large impact on the
adhesion of polystyrene latex NPs onto the cell surface of S. cerevisiae.
Thus, an isotonic NaCl concentration (154mM) was contrasted to a low
NaCl environment (5mM) in our experiments. In fact, our results show a
higher interaction between yeast cells and NPs in solutions with 5mM
NaCl compared with 154mM NaCl, for the S. cerevisiae strains BY4742
and S86c. Via CLSM and corresponding fluorescence intensity profiles,
the internalization of NPs in the cells could be verified for high NP
concentration in 5mM NaCl, whereas the particles seem to accumulate
on the cell surface at lower concentrations. These observations are in
line with the findings of Lin, Brixius, Hubbuch, Thommes, and Kula
(2003) that the zeta potential of yeast cells in absolute values decreases
with the increase of conductivity in the solution.
Even though most of the cells of both analyzed S. cerevisiae strains
showed an association with NPs, there was a tendency towards a
higher fluorescence intensity detectable for the strain BY4742. This
phenomenon can be explained by the variability in cell wall
components between the analyzed strains. It has been stated by
Bazan et al. (2014) that the chitin distribution in S86c is much higher
compared with BY4742 (i.e. 72% vs. 37% positive cells). Furthermore,
the zeta potential of BY4742 was found to be more negative
compared with S86c confirming the higher attractive electrostatic
force between BY4742 and positively charged NP. Examination of
the effect of chitosan‐coated PLGA particles on the membrane
integrity of yeast cells led to the conclusion that membrane integrity
of BY4742 is impaired in the concentration range between 0.03 and
1mg/ml in 5 mM NaCl solution, but not in 154mM NaCl. Moreover,
the loss of membrane integrity goes along with reduced viability of
the yeast cells when incubated with higher concentrated NPs (above
0.25mg/ml) in a hypotonic environment. This finding is supported by
the cell death of S. cerevisiae after incubation with positively charged
PSL nanoparticles in 5mM NaCl (Nomura et al., 2013). However, as
the developed system does not depend on the viability of the yeast,
the lethal effect is assumed not to play a role in the potential
applications of the system (Bazan et al., 2014).
It has already been shown that the internalization of S. cerevisiae
can be significantly increased for M2‐polarized MDM by opsoniza-
tion with human serum (Seif et al., 2016). This observation depends
on the fact that human serum contains opsonins, like immunoglobu-
lins and complement‐derived proteins, allowing the additional
recognition of coated yeast cells by Fc and complement receptors
of the respective phagocytes (Underhill & Goodridge, 2012). Our
results confirm an increased uptake of opsonized yeast cells in THP‐
1‐derived M1 as well as M2 MΦ. Further, we were able to verify that
preincubation with NPs does not reduce the phagocytotic efficiency
of the cells. Consequently, in coculture experiments, yeast cells not
only have the ability to provide targeted delivery of NPs to
macrophages, but deliver a higher amount of NPs compared with
NPs alone. Additionally, while plain NPs self‐aggregated in the
medium (Nafee et al., 2009), particles associated with yeast were
internalized by M1 and M2 MΦ almost completely. As BY4742 cells
show a low NP‐binding capacity in isotonic environment, the
decreased delivery efficiency compared with yeast incubated with
NPs in 5 mM NaCl is not surprising; however, the normalized
fluorescence intensity of these cells is still comparable to MΦ treated
with plain NPs confirming the effectivity of the developed system.
In conclusion, our data underline the usefulness of yeast cells as a
novel delivery vehicle for functionalized nanoparticles. Considering
the achievements already earned by using nanoparticles for immu-
notherapy, the combination with yeast cells for specific targeting to
APC might lead to a substantial progress in different therapeutic
approaches as suggested by Amoozgar and Goldberg (2015). Beyond
the cell‐specific targeting and protection of the cargo, S. cerevisiae
offers much more possibilities like modification of the cell surface
improving the application via the oral route (Kenngott et al., 2016) or
provoke an antitumor immune response (Liu et al., 2018). Future
experiments using NPs loaded with functional molecules will reveal
the full potential of yeast/NP complexes in therapeutic approaches.
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